// App-Quantinova.ai

1901 : D-Dimer As a Predictor of Thrombotic Events during Early Acute Lymphoblastic Leukemia Therapy

Researchers

Presenter

  • Wendy Stock

Principal Investigators

  • Avi Leader

  • Theodore G. Karrison

Medical Centers

  • Internal Medicine / Hematology-Oncology, University of Chicago, Chicago, IL

  • Sackler Faculty Of Medicine, Tel-Aviv University, Tel-Aviv, Israel

  • Institute of Oncology, Davidoff Center, Rabin Medical Center, Tel Aviv University, Petah Tikva, Israel

  • Public Health Sciences, Univesity of Chicago, Chicago, IL

  • Department of Medicine, Section of Hematology and Oncology, The University of Chicago, Chicago, IL

Locations

  • United States

  • Israel

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Disseminated intravascular coagulation

  • Acute lymphoblastic leukemia

  • Venous thrombosis

Biomarkers

  • Breakpoint Cluster Region

  • D-dimer

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Multinational

  • Cohort

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A